rs1555894743
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM4_SupportingPM2_Supporting
This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.530_532dup (p.Ile177_Thr178insIle) is an in-frame insertion which affects a residue within the Runt Homology domain (AA 89-294) but does not impact a residue which has been established as a hotspot (PM4_Supporting). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_supporting, PM4_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA16616526/MONDO:0100083/008
Frequency
Consequence
NM_001754.5 inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RUNX1 | NM_001754.5 | c.532_533insTCA | p.Ile177dup | inframe_insertion | 6/9 | ENST00000675419.1 | NP_001745.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RUNX1 | ENST00000675419.1 | c.532_533insTCA | p.Ile177dup | inframe_insertion | 6/9 | NM_001754.5 | ENSP00000501943 | A1 | ||
RUNX1-AS1 | ENST00000651798.1 | n.661+22611_661+22613dup | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 03, 2016 | In summary, this variant is a novel sequence change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a RUNX1-related disease. This sequence change duplicates 3 nucleotides in exon 6 of the RUNX1 mRNA (c.530_532dupTCA). This leads to the duplication of 1 amino acid residue in the RUNX1 protein (p.Ile177dup) but otherwise preserves the integrity of the reading frame. - |
Uncertain significance, reviewed by expert panel | curation | ClinGen Myeloid Malignancy Variant Curation Expert Panel | Sep 25, 2024 | NM_001754.5(RUNX1):c.530_532dup (p.Ile177_Thr178insIle) is an in-frame insertion which affects a residue within the Runt Homology domain (AA 89-294) but does not impact a residue which has been established as a hotspot (PM4_Supporting). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_supporting, PM4_supporting. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at